Clinical Trial Update: Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating whether perindopril reduces recurrence of atrial fibrillation in patients with essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Essential Hypertension

Drugs mentioned

• perindopril (perindopril)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Essential Hypertension, Atrial Fibrillation | Phase 3 | Status: COMPLETED